Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

UK researchers examine university students behavior amid COVID-19 prevention measures

A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

The focus is increasingly moving towards vaccine roll-out as the world faces the real possibility of the second year of social and economic restrictions.

14 Dec 2020

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

Less sensitive rapid tests may miss asymptomatic/presymptomatic SARS-CoV-2 infection

The rapid transmissibility of SARS-CoV-2 has posed a significant challenge to COVID-19 containment measures.

14 Dec 2020

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Researchers in the United States and Australia have conducted a comprehensive analysis of the epitope recognition patterns associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans.

14 Dec 2020

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Scientists have suggested that a proportion of the population have pre-existing immunity to COVID-19 because of T cells primed against SARS-CoV-2 antigens.

14 Dec 2020

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

In the current COVID-19 pandemic, SARS-CoV-2 has led to millions of infections worldwide, with over 1.5 million deaths.

14 Dec 2020

Recovered COVID-19 patients exhibit persistent cellular immunity

Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.

14 Dec 2020

RNA editing within host linked to SARS-CoV-2 variants

Since the start of the COVID-19 pandemic, the causative virus, SARS-CoV-2, has undergone several mutations.

14 Dec 2020

Households are a high-risk setting for SARS-CoV-2 transmission

The results of a new study have confirmed that households, and other crowded indoor environments, are high-risk settings for SARS-CoV-2 transmission.

14 Dec 2020

Case study suggests kindergartens are not SARS-CoV-2 super-spreaders

A new study by researchers at the Institute of Tropical Medicine and International Health at the Charite Universitaetsmedizin Berlin found that kindergartens are not silent transmission reservoirs.

11 Dec 2020

Structural inequalities increase risk of SARS-CoV-2 infection and mortality, study finds

A new study by researchers at Harvard found that people in less privileged neighborhoods are at a higher risk of being infected with SARS-CoV-2 and of more severe COVID-19.

11 Dec 2020

Distant residues modulate the conformational opening in SARS-CoV-2 spike protein

Scientists present an insight into the RBD dynamics with physically distant residues in the spike protein, elaborating on the importance of predicted mutations for therapeutics.

11 Dec 2020

Favipiravir does not attenuate the progression of COVID-19

Scientists have conducted an observational study to evaluate the efficacy of an anti-influenza medicine favipiravir in treating hospitalized COVID-19 patients.

11 Dec 2020

Pandemic-related selective increase in obsessive-compulsive symptoms in UK study

A new study shows how a large-scale wave of increased OC symptoms affected public behavior, such as seeking information about the pandemic.

11 Dec 2020

COVID-19 related to high anxiety and depression symptoms among physicians in Bangladesh

A study from Bangladesh, one of the poorest countries in the world, reveals a high prevalence of anxiety and depressive symptoms among frontline physicians.

11 Dec 2020

Current testing-isolation policies effectively prevent campus transmission of COVID-19

A new study, shows that while students showed a high degree of compliance with restrictive measures, they continued to contract the infection from off-campus.

11 Dec 2020

Pulmonary rehabilitation may promote recovery in severe COVID-19

A new study compares rehabilitation outcomes between COVID-19 patients and those with ordinary pneumonia, to evaluate the effectiveness of interventions.

11 Dec 2020

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Now, a study on the utility of hydroxychloroquine as prophylaxis against COVID-19, has been released in the latest issue of Annals of Internal Medicine.

10 Dec 2020

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

UK researchers examine university students behavior amid COVID-19 prevention measures

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Less sensitive rapid tests may miss asymptomatic/presymptomatic SARS-CoV-2 infection

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

Recovered COVID-19 patients exhibit persistent cellular immunity

RNA editing within host linked to SARS-CoV-2 variants

Households are a high-risk setting for SARS-CoV-2 transmission

Case study suggests kindergartens are not SARS-CoV-2 super-spreaders

Structural inequalities increase risk of SARS-CoV-2 infection and mortality, study finds

Distant residues modulate the conformational opening in SARS-CoV-2 spike protein

Favipiravir does not attenuate the progression of COVID-19

Pandemic-related selective increase in obsessive-compulsive symptoms in UK study

COVID-19 related to high anxiety and depression symptoms among physicians in Bangladesh

Current testing-isolation policies effectively prevent campus transmission of COVID-19

Pulmonary rehabilitation may promote recovery in severe COVID-19

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in